SG148823A1 - Pharmaceutical compositions of fibrinolytic agent - Google Patents

Pharmaceutical compositions of fibrinolytic agent

Info

Publication number
SG148823A1
SG148823A1 SG200400542-7A SG2004005427A SG148823A1 SG 148823 A1 SG148823 A1 SG 148823A1 SG 2004005427 A SG2004005427 A SG 2004005427A SG 148823 A1 SG148823 A1 SG 148823A1
Authority
SG
Singapore
Prior art keywords
fibrinolytic agent
pharmaceutical compositions
lyophilized
compositions
lyophilized composition
Prior art date
Application number
SG200400542-7A
Other languages
English (en)
Inventor
Brent S Kendrick
Brian Peterson
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of SG148823A1 publication Critical patent/SG148823A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG200400542-7A 1999-10-01 2000-09-29 Pharmaceutical compositions of fibrinolytic agent SG148823A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/411,335 US6440414B1 (en) 1999-10-01 1999-10-01 Pharmaceutical compositions of fibrinolytic agent

Publications (1)

Publication Number Publication Date
SG148823A1 true SG148823A1 (en) 2009-01-29

Family

ID=23628514

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200400542-7A SG148823A1 (en) 1999-10-01 2000-09-29 Pharmaceutical compositions of fibrinolytic agent

Country Status (28)

Country Link
US (4) US6440414B1 (zh)
EP (2) EP1438967A3 (zh)
JP (1) JP2003510369A (zh)
KR (1) KR100717435B1 (zh)
CN (2) CN101209347A (zh)
AT (1) ATE262923T1 (zh)
AU (1) AU769313B2 (zh)
BG (1) BG106578A (zh)
BR (1) BR0014420A (zh)
CA (1) CA2385966A1 (zh)
CZ (1) CZ20021033A3 (zh)
DE (2) DE60009529T2 (zh)
DK (1) DK1220685T3 (zh)
EA (2) EA004627B1 (zh)
ES (2) ES2218228T3 (zh)
HK (1) HK1049112B (zh)
HU (1) HUP0202654A3 (zh)
IL (1) IL148842A0 (zh)
MX (1) MXPA02003197A (zh)
NO (1) NO20021500L (zh)
NZ (4) NZ540967A (zh)
PL (1) PL355016A1 (zh)
PT (1) PT1220685E (zh)
SG (1) SG148823A1 (zh)
SK (1) SK4242002A3 (zh)
WO (1) WO2001024817A2 (zh)
YU (1) YU23302A (zh)
ZA (1) ZA200202400B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
US6440414B1 (en) 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6261820B1 (en) 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
US6455269B1 (en) * 1999-12-17 2002-09-24 Amgen, Inc. Method for localized administration of fibrinolytic metalloproteinases
US7033776B2 (en) * 1999-12-17 2006-04-25 Amgen Inc. Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
DE10149030A1 (de) * 2001-10-05 2003-04-10 Viscum Ag Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin
MXPA04007328A (es) * 2002-02-01 2005-07-05 Shimoda Biotech Pty Ltd Composicion farmaceutica.
WO2003068805A2 (en) * 2002-02-14 2003-08-21 Bayer Pharmaceuticals Corporation Formulation strategies in stabilizing peptides in organic solvents and in dried states
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
US8304387B2 (en) * 2004-12-15 2012-11-06 Swedish Orphan Biovitrum Ab (Publ) Therapeutic formulations of keratinocyte growth factor
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
AU2006316005A1 (en) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. Process for production of cinnamamide derivative
US7867747B2 (en) * 2006-11-08 2011-01-11 Korea Ocean Research And Development Institute Fibrinolytic metalloprotease and composition comprising the same
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
MX2012000475A (es) 2009-07-10 2012-03-26 Thrombogenics Nv Variantes de plasminogeno y plasmina.
CN102000022A (zh) * 2010-11-23 2011-04-06 郑州大学 注射用重组双功能纤溶酶冻干制剂及其制备方法
EP2661493B1 (en) 2011-01-05 2016-03-30 ThromboGenics N.V. Plasminogen and plasmin variants
CN103764163A (zh) 2011-08-12 2014-04-30 斯路姆基因公司 纤溶酶原和纤溶酶变体
US20140212405A1 (en) 2013-01-28 2014-07-31 2294719 Ontario Limited Fibrinolytic/Proteolytic Treatment of Myofacial and Neuropathic Pain and Related Conditions
JP6877340B2 (ja) * 2014-11-06 2021-05-26 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ 血栓溶解剤の存在下における粘弾性解析を用いた新規病態の確認
AU2020204922A1 (en) * 2019-01-06 2021-07-01 Endo Global Aesthetics Limited Collagenase formulations and methods of producing the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323722A1 (en) * 1987-12-18 1989-07-12 Chiron Corporation Compositions and method for recombinant production of crotalidus venom fibrolase
EP0689843A1 (en) * 1993-12-17 1996-01-03 Mochida Pharmaceutical Co., Ltd. Composition containing soluble thrombomodulins

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310133A2 (fr) 1975-05-05 1976-12-03 Fabre Sa Pierre Nouveau medicament comportant un activateur du plasminogene perfectionne
EP0062642B1 (en) * 1980-06-27 1986-09-10 Movement Techniques Limited Movement measuring apparatus and landmarks for use therewith
US4447236A (en) * 1982-02-05 1984-05-08 Cordis Corporation Infusion catheter system
US4610879A (en) 1984-01-06 1986-09-09 University Of Southern California Fibrinolytic enzyme from snake vernom
CA1237482A (en) * 1984-03-09 1988-05-31 Frank B. Stiles Catheter for effecting removal of obstructions from a biological duct
US4755167A (en) * 1984-04-10 1988-07-05 Research Corporation In vivo method for distribution and stirring of therapeutic agents
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4837148A (en) * 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US4885242A (en) * 1984-10-30 1989-12-05 Phillips Petroleum Company Genes from pichia histidine pathway and uses thereof
US4818700A (en) * 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) * 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US4848700A (en) * 1987-04-16 1989-07-18 Lockheed John A Canard control system for aircraft
WO1990007352A1 (en) 1989-01-04 1990-07-12 Boston Scientific Corporation Angioplasty catheter
US5222941A (en) * 1990-01-12 1993-06-29 Don Michael T Anthony Method of dissolving an obstruction in a vessel
EP0438200B1 (en) 1990-01-16 2002-07-17 Centro De Ingenieria Genetica Y Biotecnologia Method for the expression of heterologous genes in the yeast Pichia pastoris, expression vectors and transformed microorganisms
US5709676A (en) * 1990-02-14 1998-01-20 Alt; Eckhard Synergistic treatment of stenosed blood vessels using shock waves and dissolving medication
US5250034A (en) * 1990-09-17 1993-10-05 E-Z-Em, Inc. Pressure responsive valve catheter
US5167628A (en) * 1991-05-02 1992-12-01 Boyles Paul W Aortic balloon catheter assembly for indirect infusion of the coronary arteries
US5380273A (en) * 1992-05-19 1995-01-10 Dubrul; Will R. Vibrating catheter
EP0624642B1 (en) 1993-05-12 1999-01-20 Indian Council For Medical Research Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament
US5370653A (en) * 1993-07-22 1994-12-06 Micro Therapeutics, Inc. Thrombectomy method and apparatus
US5626564A (en) * 1995-03-31 1997-05-06 Creighton University Adjustable sideholes catheter
US5830468A (en) 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
US6020181A (en) * 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
DK0914102T3 (da) 1996-05-24 2006-01-09 Angiotech Pharm Inc Præparater og fremgangsmåder til behandling eller forebyggelse af syddomme i legemskanaler
US5951981A (en) 1996-12-02 1999-09-14 Diatide, Inc. Thrombolytic agents with antithrombotic activity
US6413760B1 (en) 1997-04-15 2002-07-02 Genetics Institute, Inc. Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof
US6261820B1 (en) 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
US6440414B1 (en) 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6455269B1 (en) * 1999-12-17 2002-09-24 Amgen, Inc. Method for localized administration of fibrinolytic metalloproteinases
WO2002012283A2 (en) 2000-08-03 2002-02-14 Zymogenetics, Inc. Disintegrin homologs, zsnk10, zsnk11, and zsnk12

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323722A1 (en) * 1987-12-18 1989-07-12 Chiron Corporation Compositions and method for recombinant production of crotalidus venom fibrolase
EP0689843A1 (en) * 1993-12-17 1996-01-03 Mochida Pharmaceutical Co., Ltd. Composition containing soluble thrombomodulins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AMINO ACID SEQUENCE OF FIBROLASE, A DIRECT-ACTING FIBRINOLYTIC ENZYME FROM AGKISTRODON CONTOTRIX CONTORTIX VENOM *
STABILIZATION VS. DEGRADATION OF STAPHYLOCOCCUS AUREUS METALLOPROTEINASE *

Also Published As

Publication number Publication date
EP1220685B1 (en) 2004-03-31
DE04007657T1 (de) 2005-01-13
BR0014420A (pt) 2002-06-11
CN1402641A (zh) 2003-03-12
WO2001024817A3 (en) 2001-10-18
ZA200202400B (en) 2003-05-28
AU769313B2 (en) 2004-01-22
ES2224917T1 (es) 2005-03-16
MXPA02003197A (es) 2002-09-30
EA004627B1 (ru) 2004-06-24
US7311908B2 (en) 2007-12-25
YU23302A (sh) 2005-06-10
WO2001024817A2 (en) 2001-04-12
JP2003510369A (ja) 2003-03-18
EP1438967A3 (en) 2005-01-26
ES2218228T3 (es) 2004-11-16
NZ540967A (en) 2007-02-23
BG106578A (bg) 2003-04-30
US7138114B2 (en) 2006-11-21
NZ530959A (en) 2005-08-26
HK1049112A1 (en) 2003-05-02
NO20021500D0 (no) 2002-03-26
EA006600B1 (ru) 2006-02-24
US20020192207A1 (en) 2002-12-19
US6440414B1 (en) 2002-08-27
HK1049112B (zh) 2005-01-21
EA200200396A1 (ru) 2002-10-31
CN101209347A (zh) 2008-07-02
CN100353999C (zh) 2007-12-12
DE60009529T2 (de) 2005-04-14
NZ518007A (en) 2004-03-26
US7244426B2 (en) 2007-07-17
EP1438967A2 (en) 2004-07-21
DE60009529D1 (de) 2004-05-06
NZ550200A (en) 2008-04-30
IL148842A0 (en) 2002-09-12
DK1220685T3 (da) 2004-08-02
NO20021500L (no) 2002-05-27
HUP0202654A3 (en) 2003-11-28
CA2385966A1 (en) 2001-04-12
SK4242002A3 (en) 2003-08-05
US20060263347A1 (en) 2006-11-23
ATE262923T1 (de) 2004-04-15
PL355016A1 (en) 2004-03-22
EA200400182A1 (ru) 2004-08-26
PT1220685E (pt) 2004-08-31
KR20020053065A (ko) 2002-07-04
CZ20021033A3 (cs) 2003-06-18
EP1220685A2 (en) 2002-07-10
HUP0202654A2 (hu) 2002-12-28
US20060246053A1 (en) 2006-11-02
KR100717435B1 (ko) 2007-05-14
AU7743000A (en) 2001-05-10

Similar Documents

Publication Publication Date Title
SG148823A1 (en) Pharmaceutical compositions of fibrinolytic agent
MY133996A (en) Compounds for the treatment of ischemia
EP1100522A4 (en) ADMINISTRATION OF ACTIVE SUBSTANCES BY PULMONARY TRACT
AU1750097A (en) Highly concentrated, lyophilized, and liquid factor ix formulations
NZ333380A (en) 6-O-methylerythromycin A crystal form I (clarithromycin) and preparation thereof
WO2000007979A3 (en) Compounds and compositions for delivering active agents
AU2274201A (en) Compounds and compositions for delivering active agents
HUP0104987A3 (en) Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
PT1083884E (pt) Processo para a estabilizacao de composicoes de polivinil-pirrolidona
HRP20020330B1 (zh)
AU2496199A (en) Copolymer compositions for oral delivery
HUP9701437A3 (en) Use of complex lipides as stabilizing additives in pharmaceutical compositions containing digestive enzymes, pharmaceutical compns. and kits
ES2175940T3 (es) Formulacion farmaceutica de un compuesto didemnina.
GB0128277D0 (en) Pharmaceutical compositions
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
ITMI962385A0 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi procedimento per prepararli e composizioni farmaceutiche che li contengono
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
MY121982A (en) Pharmaceutical compositions for freeze drying